PandemieGrippaleV1, Main, Merge, indexHead, Idat.i

Index : Idat.i

Les termes de plus forte occurence

3	1286-4579:2001:Reid A:the:spanish:influenza
3	0920-9964:1998:Selten J:prenatal:exposure:to
3	0378-1135:2000:Shortridge K:interspecies:transmission:of
3	0378-1135:2000:Claas E:pandemic:influenza:is
3	0309-2402:2006:Rassool G:current:issues:and
3	0300-9564:2009:Foley P:encephalitis:lethargica:and
3	0277-9536:1999:Pyle G:from:african:health
3	0277-9536:1991:Ohadike D:diffusion:and:physiological
3	0025-7273:2002:Langford C:the:age:pattern
3	0022-1899:2006:Whitley R:seasonal:and:pandemic
2	8756-7938:2005:Hoare M:bioprocess:engineering:issues
2	1935-7893:2013:Davies A:testing:the:efficacy
2	1931-3128:2016:Spyrou M:historical:y:pestis
2	1875-9572:2010:Ho T:historical:review:of
2	1874-5482:2014:Tuncer N:effect:of:air
2	1865-1674:2016:Dorjee S:one:health:simulation
2	1775-8785:2008:Gehanno J:le:medecin:du
2	1750-2640:2013:Smith R:macroeconomic:impact:of
2	1660-9379:2007:Zanetti G:pandemie:de:grippe
2	1635-0421:2008:Ezratty V:virus:influenza:pandemique
2	1635-0421:2007:Legeas M:une:pandemie:grippale
2	1600-6135:2006:Kumar D:pandemic:influenza:and
2	1567-1348:2012:Vittecoq M:study:of:influenza
2	1549-1277:2007:Colizza V:modeling:the:worldwide
2	1545-9624:2013:Gardner P:viable:viral:efficiency
2	1473-3099:2012:Simpson C:effectiveness:of:h
2	1473-3099:2009:Cauchemez S:closure:of:schools
2	1473-3099:2008:Jennings L:stockpiling:prepandemic:influenza
2	1473-3099:2008:Fedson D:confronting:an:influenza
2	1473-3099:2007:Brankston G:transmission:of:influenza
2	1473-3099:2006:Brundage J:interactions:between:influenza
2	1473-3099:2005:Witt C:a:veterinarian:s
2	1470-2118:2008:Barr H:ethical:planning:for
2	1470-0328:2012:K Llen B:vaccination:against:h
2	1467-7644:2008:D Aoust M:influenza:virus:like
2	1460-2725:2010:Mu Y:clinical:features:treatments
2	1460-2725:2010:Koegelenberg C:high:mortality:from
2	1434-6621:2010:Maritz J:pandemic:influenza:a
2	1434-193X:2008:Shibasaki M:synthetic:strategies:for
2	1424-6074:2002:Li S:seed:viruses:containing
2	1386-6532:2011:Poon L:viral:genetic:sequence
2	1386-6532:2011:Foucault M:role:for:proteases
2	1386-6532:2009:Chan K:analytical:sensitivity:of
2	1386-6532:2008:Mackay W:molecular:detection:and
2	1368-5031:2011:Theocharis G:comparison:of:characteristics
2	1359-6535:2009:Prabhu N:prophylactic:and:therapeutic
2	1359-6535:2007:Crusat M:neuraminidase:inhibitors:and
2	1359-107X:2014:Taha S:intolerance:of:uncertainty
2	1359-107X:2012:Teasdale E:the:importance:of
2	1355-0284:2008:Mccall S:the:relationship:between
2	1326-0200:2006:Clothier H:geographic:representativeness:for
2	1323-1316:2012:Matsuishi K:psychological:impact:of
2	1201-9712:2007:Cheng K:what:happened:in
2	1198-743X:2010:D Ortenzio E:a:review:of
2	1188-4169:2018:Henry B:canadian:pandemic:influenza
2	1188-4169:2018:Henry B:canada:s:pandemic
2	1170-229X:2008:Kasten M:influenza:vaccination:and
2	1080-6040:2009:Macintyre C:face:mask:use
2	1080-6040:2008:Oshitani H:major:issues:and
2	1080-6040:2004:Drancourt M:genotyping:orientalis:like
2	1058-4838:2013:Richards J:neonatal:outcomes:after
2	1058-4838:2011:Hernandez J:clinical:experience:in
2	1058-4838:2011:Charu V:mortality:burden:of
2	1058-4838:2010:Morens D:pandemic:influenza:s
2	1058-4838:2010:Mccullers J:recipients:of:vaccine
2	1058-4838:2009:Beigi R:economic:value:of
2	1058-4838:2008:Trilla A:the:spanish:flu
2	1058-4838:2008:Monto A:seasonal:and:pandemic
2	1058-4838:2008:Bartlett J:the:current:status
2	1058-4838:2007:Hota S:antivirals:and:the
2	1058-4838:2007:Apisarnthanarak A:issues:relevant:to
2	1058-4838:2006:Ortiz J:a:national:survey
2	1058-4838:2006:Fedson D:pandemic:influenza:a
2	1058-4838:2005:Kaye D:avian:influenza:viruses
2	1058-4838:2003:Fedson D:pandemic:influenza:and
2	1058-4838:2002:Strikas R:influenza:pandemic:preparedness
2	1058-4838:2001:Luk J:observations:on:mortality
2	1058-4838:2000:Schoch Spana M:implications:of:pandemic
2	1058-4838:1999:Webster R:potential:advantages:of
2	1044-3983:2014:Huang K:the:us:a
2	1044-3983:2013:Wong J:case:fatality:risk
2	1044-3983:2007:Glass K:how:much:would
2	1025-496X:2005:Paget J:considerable:progress:in
2	1025-496X:2005:Ciotti M:results:of:survey
2	1025-496X:2002:Karcher F:plan:de:preparation
2	1025-496X:2002:Fock R:la:pandemie:de
2	1025-496X:2001:Paget W:les:plans:de
2	1004-3756:2013:Araz O:integrating:complex:system
2	0959-8138:2006:Moriarty K:the:influenza:pandemic
2	0959-8138:2004:Balicer R:tackling:the:next
2	0959-8138:2003:Zambon M:sudden:acute:respiratory
2	0959-8138:2003:Sheldon T:the:virus:hunter
2	0959-8138:1997:White R:when:the:next
2	0956-5663:2010:Chang Y:detection:of:swine
2	0956-3202:2007:Oxford J:the:threat:of
2	0951-631X:2003:Tognotti E:scientific:triumphalism:and
2	0951-631X:1994:Killingray D:the:influenza:pandemic
2	0950-2688:2013:Richard V:what:can:the
2	0950-2688:2013:Foster E:acute:myocardial:infarctions
2	0950-2688:2010:Shi P:modelling:seasonality:and
2	0950-2688:2010:Mclean E:pandemic:h:n
2	0950-2688:2010:Cowling B:face:masks:to
2	0950-2688:2009:Yuan J:reported:changes:in
2	0950-2688:2009:Richard S:a:comparative:study
2	0950-2688:2008:Rizzo C:scenarios:of:diffusion
2	0950-2688:2007:Duerr H:the:impact:of
2	0943-1853:2011:Naing C:knowledge:about:the
2	0939-6411:2012:Kim Y:increased:immunogenicity:of
2	0934-9723:2012:Saxena R:pandemism:of:swine
2	0934-9723:2010:Falagas M:epidemiological:aspects:of
2	0934-9723:2007:Beaumont M:a:survey:of
2	0931-0509:2009:Marcelli D:influenza:a:h
2	0929-693X:2008:Guery B:organisation:de:la
2	0928-8244:1997:Webster R:influenza:interspecies:transmission
2	0928-4249:2010:Busquets N:experimental:infection:with
2	0928-4249:2007:Van Reeth K:avian:and:swine
2	0924-8579:2010:Falagas M:treatment:options:for
2	0923-2532:2010:Agut H:la:grippe:est
2	0920-9964:1999:Selten J:prenatal:exposure:to
2	0903-4641:2010:Piwpankaew Y:distribution:of:viral
2	0899-823X:2005:Cinti S:preparing:for:pandemic
2	0893-8512:2012:Cheng V:two:years:after
2	0891-3668:2012:Fawkner Corbett D:the:impact:of
2	0891-3668:2012:Ede L:effect:of:the
2	0891-3668:2010:Ampofo K:association:of:pandemic
2	0891-3668:2008:Vesikari T:emerging:data:on
2	0891-3668:2008:Vajo Z:safety:and:immunogenicity
2	0891-3668:2008:Mccullers J:preparing:for:the
2	0891-3668:2008:Huber V:vaccines:against:pandemic
2	0891-3668:2005:Reichert T:preparing:for:the
2	0891-3668:2005:Perez D:avian:influenza:an
2	0891-3668:2004:Heymann A:influence:of:school
2	0891-3668:2004:Hayden F:pandemic:influenza:is
2	0891-3668:2004:Fedson D:vaccination:for:pandemic
2	0885-3924:2010:Downar J:palliating:a:pandemic
2	0803-5253:2012:Smit P:characterization:of:h
2	0767-0974:2009:Loulergue P:vaccins:pandemiques:et
2	0742-3071:2011:Zuccotti G:long:lasting:immunogenicity
2	0740-8218:1983:Ensley P:indiana:and:the
2	0737-1209:2010:Yonge O:willingness:of:university
2	0737-1209:2007:Macario E:preparing:public:health
2	0724-8741:2008:Amorij J:development:of:stable
2	0399-077X:2000:Mouton Y:recommandations:du:groupe
2	0393-2990:2012:Redlberger Fritz M:attributable:deaths:due
2	0393-2990:2011:Keil U:the:invention:of
2	0393-2990:2011:Gilles I:trust:in:medical
2	0393-2990:2011:Ferrante G:surveillance:of:perceptions
2	0393-2990:2011:Donker T:nowcasting:pandemic:influenza
2	0393-2990:2009:Raude J:lay:perceptions:of
2	0393-2990:2006:Van Der Heide D:no:effect:of
2	0393-2990:2003:Grais R:assessing:the:impact
2	0390-6078:2011:Ljungman P:outcome:of:pandemic
2	0378-1135:2012:Njabo K:pandemic:a:h
2	0378-1135:2011:Moreno A:novel:h:n
2	0378-1135:2010:Kalthoff D:highly:pathogenic:avian
2	0377-8231:2009:Snacken R:influenza:a:h
2	0342-4642:2011:Patroniti N:the:italian:ecmo
2	0342-4642:2011:Cuquemelle E:can:procalcitonin:help
2	0342-4642:2011:Bertolini G:is:influenza:a
2	0342-4642:2010:Sprung C:recommendations:for:intensive
2	0342-4642:2010:Ingram P:procalcitonin:and:c
2	0342-4642:2010:Eastman N:triaging:for:adult
2	0340-6199:2011:Lera E:clinical:and:epidemiological
2	0310-057X:2011:Boots R:experience:with:high
2	0309-0167:2012:Bal A:pathology:and:virology
2	0305-7453:2012:Delgado Rodriguez M:prognosis:of:hospitalized
2	0305-7453:2010:Reddy D:responding:to:pandemic
2	0305-7453:2006:Democratis J:use:of:neuraminidase
2	0305-7453:2005:Ward P:oseltamivir:tamiflu:and
2	0305-7453:2004:Oxford J:a:new:millennium
2	0304-8608:2011:Wanitchang A:atypical:characteristics:of
2	0304-8608:2010:Tolnay A:extrapulmonary:tissue:responses
2	0304-8608:2008:Lupfer C:inhibition:of:influenza
2	0304-8608:2000:Olsen C:virologic:and:serologic
2	0304-8608:2000:Okazaki K:precursor:genes:of
2	0304-8608:1996:Anchlan D:previous:h:n
2	0300-8126:2011:Poeppl W:clinical:aspects:of
2	0300-8126:2011:Linhart Y:excess:mortality:from
2	0300-8126:2009:Michaelis M:an:influenza:a
2	0300-8126:2008:Lau J:perceptions:related:to
2	0300-5771:2007:Vynnycky E:estimates:of:the
2	0300-2977:2005:Groeneveld K:use:of:antiviral
2	0294-0337:2013:Aranzazu A:le:reseau:mondial
2	0277-9536:2012:Bensimon C:the:duty:to
2	0277-9536:2009:Noymer A:testing:the:influenza
2	0277-9536:2006:Mamelund S:a:socially:neutral
2	0277-9536:1983:Patterson K:the:diffusion:of
2	0277-0008:2006:Ford S:pandemics:avian:influenza
2	0272-4332:2013:Santos J:risk:based:input
2	0266-8254:2011:Kitajima M:dose:response:time
2	0264-410X:2014:Davila Payan C:system:factors:to
2	0264-410X:2013:Pulcini C:factors:associated:with
2	0264-410X:2011:Saglanmak N:gradual:changes:in
2	0264-410X:2011:Noymer A:the:influenza:pandemic
2	0264-410X:2011:Khurana S:recombinant:ha:produced
2	0264-410X:2011:Hatta Y:an:m:cytoplasmic
2	0264-410X:2011:Ellebedy A:impact:of:prior
2	0264-410X:2011:Cotte L:factors:associated:with
2	0264-410X:2011:Chowell G:the:influenza:pandemic
2	0264-410X:2010:Van Der Weijden C:the:duty:to
2	0264-410X:2010:Schwarzinger M:positive:attitudes:of
2	0264-410X:2010:Lee B:a:computer:simulation
2	0264-410X:2009:Shoji Y:immunogenicity:of:hemagglutinin
2	0264-410X:2009:Patel A:evaluation:of:conserved
2	0264-410X:2009:Pareek M:willingness:of:healthcare
2	0264-410X:2009:Lau Y:a:tlr:ligand
2	0264-410X:2009:Ikeno D:a:prime:boost
2	0264-410X:2009:De Vries J:incorporation:of:lpxl
2	0264-410X:2008:Williams T:quantification:of:influenza
2	0264-410X:2008:Toro H:protection:of:chickens
2	0264-410X:2008:Nolan T:safety:and:immunogenicity
2	0264-410X:2008:Mylius S:optimal:allocation:of
2	0264-410X:2008:Hu A:microcarrier:based:mdck
2	0264-410X:2007:Laddy D:immunogenicity:of:novel
2	0264-410X:2007:Hughes K:yield:increases:in
2	0264-410X:2006:Oxford J:scientific:lessons:from
2	0264-410X:2006:Kieny M:a:global:pandemic
2	0264-410X:2006:Hak E:modelling:the:health
2	0264-410X:2006:Flahault A:strategies:for:containing
2	0264-410X:2006:Desheva J:characterization:of:an
2	0264-410X:2006:Chowell G:estimation:of:the
2	0264-410X:2005:Pushko P:influenza:virus:like
2	0264-410X:2005:Oxford J:a:new:european
2	0264-410X:2005:Oxford J:a:hypothesis:the
2	0264-410X:2003:Wood J:the:influenza:vaccine
2	0264-410X:2003:Cox N:influenza:pandemic:planning
2	0264-410X:2002:Hilleman M:realities:and:enigmas
2	0245-7466:2009:Raude J:les:francais:a
2	0196-6553:2013:Beckman S:evaluation:of:respiratory
2	0196-6553:2009:Hashikura M:stockpile:of:personal
2	0196-6553:2007:Goldrick B:pandemic:influenza:what
2	0196-0644:2010:Kellermann A:web:based:self
2	0195-6701:2011:Zhou Y:seroprevalence:of:antibody
2	0195-6701:2009:Phin N:personal:protective:equipment
2	0195-6701:2006:Tang J:factors:involved:in
2	0193-936X:1996:Glezen W:emerging:infections:pandemic
2	0166-3542:2013:Chen H:inhibitory:and:combinatorial
2	0166-3542:2012:Lee S:targeting:the:host
2	0166-3542:2010:Sakabe S:a:cross:reactive
2	0166-0934:2010:Ducatez M:genotyping:assay:for
2	0166-0934:2010:Cheung T:evaluation:of:novel
2	0146-6615:2013:Sam I:seroprevalence:of:seasonal
2	0146-6615:2013:Pilorge L:rhinoviruses:as:an
2	0146-6615:2012:Thiberville S:the:viral:etiology
2	0146-6615:2012:Poeppl W:pre:and:post
2	0146-6615:2012:Boonarkart C:case:report:increased
2	0146-6615:2011:Samuel D:monoclonal:antibodies:to
2	0146-6615:2010:Zaraket H:antiviral:drug:susceptibilities
2	0146-6615:2010:Mak G:sero:immunity:and
2	0146-6615:2010:Liu S:pandemic:characteristics:and
2	0146-6615:2010:Lam W:development:and:comparison
2	0146-6615:2008:Lin J:genetic:and:antigenic
2	0146-6615:2007:Reece P:neuraminidase:inhibitor:resistance
2	0146-6615:2007:Ichinohe T:prophylactic:effects:of
2	0146-6615:2004:Yap F:excess:hospital:admissions
2	0143-005X:2008:Li F:finding:the:real
2	0143-005X:2006:Doyle A:influenza:pandemic:preparedness
2	0141-9889:2013:Sherlaw W:why:the:french
2	0140-6736:2006:Coker R:pandemic:influenza:preparedness
2	0140-6736:2005:Tsang K:h:n:influenza
2	0140-6736:1996:Jack D:getting:ready:for
2	0140-6736:1971:Janerich D:relationship:between:the
2	0125-1562:2007:Nishiura H:household:and:community
2	0125-1562:2006:Bhatia R:preventing:avian:influenza
2	0105-2896:2011:Dormitzer P:influenza:vaccine:immunology
2	0105-2896:2008:Maines T:pathogenesis:of:emerging
2	0098-7921:2005:Smil V:the:next:years
2	0095-1137:2011:Veguilla V:sensitivity:and:specificity
2	0095-1137:2011:Raboni S:laboratory:diagnosis:epidemiology
2	0095-1137:2009:Leblanc J:switching:gears:for
2	0095-1137:2006:Lodes M:use:of:semiconductor
2	0095-1137:2000:Fouchier R:detection:of:influenza
2	0091-6765:2011:Singer A:assessing:the:ecotoxicologic
2	0090-3493:2010:Mitchell M:a:systematic:review
2	0090-0036:2014:Vellozzi C:cumulative:risk:of
2	0090-0036:2012:Gilchrist S:benefits:and:effectiveness
2	0090-0036:2009:Vaughan E:effective:health:risk
2	0090-0036:2009:Stevenson E:pandemic:influenza:planning
2	0090-0036:2009:Steege A:pandemic:influenza:and
2	0090-0036:2009:Rust G:role:of:the
2	0090-0036:2009:Maruschak L:pandemic:influenza:and
2	0090-0036:2009:Hutchins S:protection:of:racial
2	0090-0036:2009:Hobday R:the:open:air
2	0090-0036:2009:Heffelfinger J:pandemic:influenza:implications
2	0090-0036:2009:Groom A:pandemic:influenza:preparedness
2	0090-0036:2009:Farrell R:pandemic:influenza:and
2	0090-0036:2009:Campbell V:preparing:for:and
2	0090-0036:2009:Bouye K:pandemic:influenza:preparedness
2	0090-0036:2008:Doshi P:trends:in:recorded
2	0070-217X:2009:Yen H:pandemic:influenza:as
2	0070-217X:2009:O Neill E:generation:and:characterization
2	0070-217X:2009:Horimoto T:designing:vaccines:for
2	0070-217X:2009:Baylor N:considerations:for:licensure
2	0066-4812:2013:Everts J:announcing:swine:flu
2	0066-4812:2009:Wallace R:breeding:influenza:the
2	0048-9697:2008:Bartels P:the:environmental:fate
2	0043-3144:2010:Ramjeesingh D:an:intense:influenza
2	0042-9686:2012:Van Kerkhove M:epidemic:and:intervention
2	0042-9686:2012:Rajatonirina S:short:message:service
2	0042-6822:1984:Nakajima K:genetic:relatedness:between
2	0041-1132:2012:Kreil T:preparation:of:commercial
2	0041-1132:2010:Wong H:practical:limitations:of
2	0041-1132:2010:Tsubokura M:the:impact:of
2	0041-1132:2010:Kamp C:management:of:blood
2	0041-1132:2007:Zimrin A:planning:for:pandemic
2	0041-1132:2007:Kreil T:h:n:influenza
2	0040-6376:2010:Nguyen Van Tam J:risk:factors:for
2	0040-6376:2010:Fajardo Dolci G:clinical:characteristics:of
2	0037-9085:2012:D Alessandro E:pandemie:grippale:a
2	0037-9085:2011:Staikowsky F:caracteristiques:des:syndromes
2	0037-5675:2011:Siau C:influenza:a:h
2	0037-5675:2010:Voo T:influenza:pandemic:and
2	0036-8075:2009:Fraser C:pandemic:potential:of
2	0036-8075:2009:Ekiert D:antibody:recognition:of
2	0036-8075:1997:Taubenberger J:initial:genetic:characterization
2	0036-5548:2008:Kolte I:the:spanish:flu
2	0033-3549:2011:Lovegrove M:emergency:department:visits
2	0033-3549:2010:Tomes N:destroyer:and:teacher
2	0033-3549:2010:Stern A:better:off:in
2	0033-3549:2010:Keeling A:alert:to:the
2	0033-3549:2010:Byerly C:the:u:s
2	0033-3549:2010:Bristow N:it:s:as
2	0032-5473:2010:To K:concurrent:comparison:of
2	0032-5473:2007:Sellwood C:bird:flu:if
2	0028-4793:2010:Cowling B:comparative:epidemiology:of
2	0028-1042:1994:Ertel S:influenza:pandemics:and
2	0028-0836:2012:Morens D:engineering:h:n
2	0028-0836:2012:Everitt A:ifitm:restricts:the
2	0028-0836:2011:Vijaykrishna D:long:term:evolution
2	0028-0836:2009:Smith G:origins:and:evolutionary
2	0028-0836:2009:Neumann G:emergence:and:pandemic
2	0028-0836:2009:Ginsberg J:detecting:influenza:epidemics
2	0028-0836:2008:Cauchemez S:estimating:the:impact
2	0028-0836:2006:Kash J:genomic:analysis:of
2	0028-0836:2006:Ferguson N:strategies:for:mitigating
2	0028-0836:2005:Taubenberger J:characterization:of:the
2	0028-0836:2005:Ferguson N:strategies:for:containing
2	0028-0836:2004:Mills C:transmissibility:of:pandemic
2	0028-0836:2004:Kobasa D:enhanced:virulence:of
2	0026-4695:2010:Van Rijswoud E:virology:experts:in
2	0025-729X:2010:Seale H:examining:the:knowledge
2	0025-729X:2010:Flint S:disproportionate:impact:of
2	0025-729X:2010:Beaman M:pandemic:influenza:testing
2	0025-729X:2009:Senanayake S:a:pandemic:that
2	0025-729X:2009:Seale H:the:community:s
2	0025-729X:2009:Mccaw J:understanding:australia:s
2	0025-729X:2008:Anikeeva O:how:will:australian
2	0025-729X:2006:Horvath J:the:australian:response
2	0025-729X:2006:Harrod M:antivirals:in:the
2	0025-729X:2006:Collignon P:infection:control:and
2	0025-729X:2006:Boyd M:pandemic:influenza:clinical
2	0025-7273:2005:Reid A:the:effects:of
2	0025-6196:2010:Tosh P:influenza:vaccines:from
2	0025-6196:2010:Sullivan S:h:n:influenza
2	0025-6196:2004:Trampuz A:avian:influenza:a
2	0024-7758:2009:Beigi R:acceptance:of:a
2	0022-538X:2012:Wong D:comparable:fitness:and
2	0022-538X:2011:Hillaire M:characterization:of:the
2	0022-538X:2011:Cline T:increased:pathogenicity:of
2	0022-538X:2011:Chan R:tissue:tropism:of
2	0022-538X:2010:Khatri M:swine:influenza:h
2	0022-538X:2010:Boon A:cross:reactive:neutralizing
2	0022-538X:2009:Perrone L:intranasal:vaccination:with
2	0022-538X:2009:Middleton D:evaluation:of:vaccines
2	0022-538X:2009:Kugel D:intranasal:administration:of
2	0022-538X:2009:Dunham E:different:evolutionary:trajectories
2	0022-538X:2008:Murakami S:growth:determinants:for
2	0022-538X:2008:Bouvier N:oseltamivir:resistant:influenza
2	0022-538X:2007:Yen H:neuraminidase:inhibitor:resistant
2	0022-538X:2007:Kochs G:multiple:anti:interferon
2	0022-538X:2005:Tumpey T:pathogenicity:of:influenza
2	0022-5045:2009:Eyler J:the:fog:of
2	0022-4391:2013:Miller J:use:of:nonpharmaceutical
2	0022-3549:2011:Andrianov A:pcpp:formulated:h
2	0022-3166:2009:Schwerbrock N:fish:oil:fed
2	0022-3069:2001:Reid A:experimenting:on:the
2	0022-3069:2001:Mccall S:influenza:rna:not
2	0022-1899:2012:Orelle A:epidemiological:and:virological
2	0022-1899:2012:Kouassi D:vulnerable:groups:within
2	0022-1899:2012:Jackson L:immunogenicity:and:safety
2	0022-1899:2012:Heraud J:spatiotemporal:circulation:of
2	0022-1899:2011:Launay O:safety:and:immunogenicity
2	0022-1899:2011:Bloom Feshbach K:natality:decline:and
2	0022-1899:2010:Van Den Brand J:severity:of:pneumonia
2	0022-1899:2010:Kobinger G:assessment:of:the
2	0022-1899:2010:Chowell G:mortality:patterns:associated
2	0022-1899:2010:Chien Y:efficacy:of:whole
2	0022-1899:2009:Ehrlich H:a:cell:culture
2	0022-1899:2008:Miller M:prioritization:of:influenza
2	0022-1899:2008:Hoelscher M:a:broadly:protective
2	0022-1899:2008:Fineberg H:preparing:for:avian
2	0022-1899:2008:Barry J:cross:protection:between
2	0022-1899:2008:Barrett R:stigma:in:the
2	0022-1899:2008:Andreasen V:epidemiologic:characterization:of
2	0022-1899:2007:Morens D:the:influenza:pandemic
2	0022-1899:2006:Garcia Sastre A:lessons:learned:from
2	0022-1899:2006:Fauci A:seasonal:and:pandemic
2	0022-1899:2005:Viboud C:multinational:impact:of
2	0022-1899:1998:Stilianakis N:emergence:of:drug
2	0022-1899:1997:Webster R:predictions:for:future
2	0022-1899:1997:Patriarca P:influenza:pandemic:preparedness
2	0022-1899:1997:Monto A:prospects:for:pandemic
2	0022-1899:1977:Hilleman M:serologic:responses:to
2	0021-8537:1981:Ohadike D:the:influenza:pandemic
2	0021-2571:2003:Donatelli I:who:influenza:global
2	0020-1324:2010:Gilbert C:novel:h:n
2	0019-5456:2009:Sebastian M:swine:origin:influenza
2	0018-2648:2013:Fletcher A:reviews:and:short
2	0014-2972:2011:Lee M:m:specific:reverse
2	0012-835X:2005:Adungo F:influenza:the:next
2	0012-3692:2010:Hui D:clinical:management:of
2	0012-3692:2009:Hui D:exhaled:air:and
2	0012-3692:2008:Rubinson L:definitive:care:for
2	0012-3692:2006:Wong S:avian:influenza:virus
2	0009-9236:2007:Hoelscher M:new:pre:pandemic
2	0009-9236:2007:Gray G:the:importance:of
2	0009-9147:2010:Poon L:rapid:detection:of
2	0009-9147:2009:Poon L:molecular:detection:of
2	0008-4263:2005:Tam T:fortune:favours:the
2	0008-4263:2005:Kort R:ensuring:a:broad
2	0008-4263:2004:Doxtator L:responding:to:pandemic
2	0007-5140:2003:Afkhami A:compromised:constitutions:the
2	0007-5140:2002:Johnson N:updating:the:accounts
2	0007-1420:2005:Stephenson I:influenza:current:threat
2	0007-1048:2010:Launes C:pandemic:influenza:a
2	0006-4971:2010:Casper C:how:i:treat
2	0003-9888:2011:Smith H:are:the:uk
2	0003-9888:2009:Ercole A:modelling:the:impact
2	0003-9888:2008:Nicoll A:children:avian:influenza
2	0003-4878:2009:Viscusi D:evaluation:of:five
2	0003-4819:2014:Khazeni N:health:and:economic
2	0003-4819:2011:Tsatsaris V:maternal:immune:response
2	0003-4819:2009:Khazeni N:effectiveness:and:cost
2	0003-2409:2005:Menon D:modelling:the:impact
2	0002-9629:2010:Farley M:h:n:influenza
2	0002-9483:2009:Sawchuk L:brief:communication:rethinking
2	0002-9440:2010:Shieh W:pandemic:influenza:a
2	0002-9440:2010:Chan M:tropism:and:innate
2	0002-9378:2012:Rasmussen S:practices:of:obstetrician
2	0002-9378:2011:Mendez Figueroa H:neonatal:characteristics:and
2	0002-9262:2014:Pelat C:optimizing:the:precision
2	0002-9262:2011:Fraser C:influenza:transmission:in
2	0002-9262:2009:Wood J:optimal:dosing:and
2	0002-9262:2004:Reichert T:influenza:and:the
2	0002-8614:2014:Lum H:pandemic:influenza:plans
2	0002-8614:2011:Enserink R:absence:of:influenza
2	0002-8614:2007:Mody L:pandemic:influenza:planning
2	0001-706X:2002:Capua I:avian:influenza:and
2	0001-5172:2012:Brink M:respiratory:support:during
2	0001-5172:2010:Pahlman I:pandemic:influenza:human
1	8756-7938:2007:Zhang H:prediction:of:shear
1	8756-7938:2006:Listner K:development:of:a
1	8755-6863:2020:Yilmaz O:brief:report:international
1	8755-6863:2011:Zheng Y:hospitalized:children:with
1	8755-6863:2011:Yeo Hyang Kim:cytokine:response:in
1	8755-6863:2011:Soyer O:parental:perspectives:on
1	8755-6863:2011:Sharp J:bronchoscopic:findings:in
1	8755-6863:2010:Squires K:h:n:influenza
1	8755-6863:2010:Sert A:an:unusual:cause
1	8755-6863:2009:Hon K:just:like:sars
1	8755-0229::Wahlen M:improving:influenza:vaccine
1	8755-0229::Dunn S:prepare:your:practice
1	2677-7193:2020:Guidere M:psycholinguistic:assessment:of
1	2555-7017:2020:Pache G:debat:sur:le
1	2555-7017:2020:Pache G:covid:logistics:at
1	2552-2078:2020:Sardon J:from:the:long
1	2552-2078:2020:Dumont G:covid:the:end
1	2511-2104:2020:Yamin M:counting:the:cost
1	2431-2134:2020:Roumeau E:essais:cliniques:en
1	2431-2134:2020:Pison G:la:statistique:publique
1	2431-2134:2020:Lambert A:logement:comment:la
1	2431-2134:2020:Grandcolas P:covid:ou:la
1	2431-2134:2020:Grandcolas P:covid:or:the
1	2431-2134:2020:Fulconis F:coronavirus:un:revelateur
1	2431-2134:2020:Crepey P:covid:en:france
1	2431-2134:2020:Chambaud L:repenser:fondamentalement:le
1	2431-2134:2020:Cerisier J:covid:ce:que
1	2399-3642:2018:Yen P:synthetic:mirnas:induce
1	2387-4597:2020:Ferrand F:french:civil:justice
1	2369-2960:2020:Ohannessian R:global:telemedicine:implementation
1	2356-6140:2014:Ullah R:multiple:control:strategies
1	2352-3964:2018:Mourez T:hiv:rapid:screening
1	2352-3964:2016:Brault J:comparative:analysis:between
1	2352-0817:2020:Kaul D:an:overview:of
1	2347-3584:2016:Chavan R:differential:proteomic:analysis
1	2330-8125:2015:Trivedi M:biochemical:differentiation:and
1	2330-1635:2016:Pan X:science:communication:and
1	2327-6886:2014:Kung Y:a:quality:improvement
1	2326-5094:2018:Adhikari B:estimating:weekly:call
1	2326-5094:2017:Kao H:taiwan:s:experience
1	2326-5094:2017:Fischer L:how:is:cdc
1	2326-5094:2015:Pillai S:clinician:beliefs:and
1	2319-4170:2019:Gordon S:legacy:of:the
1	2319-4170:2018:Mcmichael A:legacy:of:the
1	2319-4170:2018:Gordon S:legacy:of:the
1	2311-2638:2020:Carmona Gutierrez D:digesting:the:crisis
1	2297-1769:2018:Destoumieux Garz N D:the:one:health
1	2296-2565:2019:Ramamurthy T:revisiting:the:global
1	2287-3651:2014:Lee B:assessment:of:momv
1	2287-3651:2013:Song J:long:term:immunogenicity

Manipulations en shell (Unix/Dilib)

HfdCat /Users/jacquesducloy/Documents/WicriRoot/Wicri/Sante/explor/PandemieGrippale.storage/PandemieGrippaleV1/Data/Main/Merge/Idat.i.hfd| SxmlCut idx/l | grep ...

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021

	Serveur d'exploration sur les pandémies grippales - Merge (Accueil) Index « Idat.i » - tête de navigation
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les pandémies grippales - Merge (Accueil)Index « Idat.i » - tête de navigation

Index : Idat.i

Les termes de plus forte occurence

Manipulations en shell (Unix/Dilib)

Serveur d'exploration sur les pandémies grippales - Merge (Accueil)

Index « Idat.i » - tête de navigation